psychotherapeutic drug


Also found in: Dictionary, Thesaurus, Legal, Encyclopedia.

psychotherapeutic drug

A drug to improve the principal symptoms, e.g., anxiety, depression, and psychosis, in the mentally disturbed.
See also: drug
References in periodicals archive ?
Among the disabled, psychotherapeutic drugs were the most commonly mentioned; the use of this class of drug dropped dramatically with beneficiaries 65 years of age or olden The frequency of cardiac drugs and cardiovascular drugs followed similar trends through 74 years of age.
Lisa Pamintuan, president of New York College of Health Professions, stated, "While particular emphasis is being placed on the use of psychotherapeutic drugs, the patent can actually include virtually any medication, including the monitoring of the elderly and others that simply should be properly dosed.
Moreover, the website says approximately 50 million Americans aged 12 or older reported non-medical use of any psychotherapeutic at some point in their lifetimes, while nearly 7 million Americans aged 12 or older reported current use of psychotherapeutic drugs for non-medical purposes, representing 2.
Slower metabolism by the enzyme CYP2Cl9 has been observed in people of Asian descent after using some psychotherapeutic drugs, when compared with white and blacks.
Neurogen, based in Branford, Connecticut, is engaged in the design and development of receptor subtype specific psychotherapeutic drugs based on advances in molecular biology, medicinal chemistry and neurobiology for the treatment of anxiety, psychosis, epilepsy, dementia, depression, and sleep, eating and stress related disorders.
9 million persons aged 12 or older who used prescription-type psychotherapeutic drugs non-medically in the past month.
18 /PRNewswire/ -- Based on the steadily increasing success of current drugs on the market as well as the potential success of numerous drugs currently in late stage development or awaiting regulatory approval, sales of psychotherapeutic drugs treating everything from schizophrenia and depression to ADHD and anxiety are expected to reach nearly $50 billion by 2010, according to a new report from life science research firm Kalorama Information.
Neurogen is engaged in the design and development of receptor subtype specific psychotherapeutic drugs based on advances in molecular biology, medicinal chemistry and neurobiology for the treatment of anxiety, psychosis, epilepsy, dementia, depression, and sleep, eating and stress related disorders.
In 2004, most of the people using drugs other than marijuana used psychotherapeutic drugs non medically (6.